107 results about "Injected drug" patented technology

An ultra-miniaturized wireless-controlled patch-type drug pump and a production method thereof, in the field of biomedical engineering device technology, are disclosed. The pump utilizes near-field communication (NFC) technology commonly found in smartphones to power the circuit. It injects drug into patients' bodies via volume alteration of a thermal expansion material and a gas generated by an electrolytic electrode, attaining pre-meal bolus and basal rate drug infusion. The drug pump has a relatively simple structure, a small size, and no need for an internal power supply, thereby alleviating at least some of the burden on patients and enhancing the comfort and convenience of wearing the pump. Meanwhile, it can be controlled through a smartphone application, simplifying the operation(s) of the pump and providing users with a precise and convenient drug injection approach.

The present invention relates to a drug injection multi-needle of which the surface to come into contact with the skin provides either a cooling or warming sensation so that pain can be reduced and, simultaneously, a hemostatic effect can be increased and, specifically, comprises: an injection part to which a drug syringe for storing a drug is coupled and into which the drug is injected by means of pressure; a needle coupling part which is coupled to the front surface of the injection part and to which a plurality of needles to penetrate the skin are coupled; a suction part into which the needle coupling part is inserted and which suctions air at a position coming into contact with the skin; and a temperature-regulating part which is formed on the front surface of the suction part and which regulates the temperature.

The invention belongs to the technical field of biological medicines, and discloses a B cell and cartilage cell senescence targeting osteoarthritis treatment medicine. The invention provides an application of an anti-MIF antibody or an antigen binding fragment thereof as a B cell targeting immunomodulator in osteoarthritis treatment drugs, the anti-MIF antibody or the antigen binding fragment thereof regulates and controls an MIF / HMGB1 / MMP13 signal axis through a neutralization effect with MIF, so that the MIF and B cells are significantly co-localized, expression of HMGB1 in the B cells is promoted, and the osteoarthritis treatment effect is improved. The senescence of B cells is reduced and the B cells are promoted to regulate or repair phenotype transformation so as to destroy chronic inflammatory circulation and diffusion of pathogenic plasma cells, and the expression of MMP13 in joint tissues is reduced so as to maintain the steady state of cartilage tissues; the preparation method has an excellent application prospect in preparation of an OA intra-articular injection drug which realizes rapid anti-inflammatory and long-term cartilage protection effects and can realize a lasting curative effect through low-frequency drug delivery.

1. Name of the product in this design: Pen-type Injector (DP1-1). 2. Purpose of this design: For injecting drugs. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1. 5. Other situations requiring explanation: The top view enlarged view is an enlarged view of the top view; the bottom view enlarged view is an enlarged view of the bottom view.

1. Name of the product in this design: Pen-type Injector (WH-DH3). 2. Purpose of this design: For injecting drugs. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1. 5. Other situations requiring explanation: The top view enlarged view is an enlarged view of the top view; the bottom view enlarged view is an enlarged view of the bottom view.

The invention relates to an injection device (1) for injecting a pharmaceutical substance, comprising a proximal portion (5) having an actuator (7) for performing an injection, and comprising a distal portion (13) designed to receive an injection loading portion (3), which in turn has a container receiving portion (17) and a primary container (23) retained in the container receiving portion (17), in which a pharmaceutical substance is contained, wherein the pharmaceutical substance can be injected from the injection loading portion (3) if the injection loading portion (3) is disposed in the distal portion (3), wherein the distal portion (13) is designed so that the injection loading portion (3) can be axially inserted into the distal portion (13).and wherein the injection device (1) has a visual display (15) that is designed and arranged so that an injection needle (25) of the injection loading portion (3) is concealed from the user during use of the injection device (1).

1. Name of the design product: Auxiliary injection pusher. 2. Use of the design product: To assist in injecting drugs. 3. Design key points of the design product: The shape. 4. Picture or photograph that best shows the design key points: Combined state diagram.

An intelligent dosing platform incorporating comprehensive predictive analytics and forecasting capabilities for injectable medication administration. The platform includes predictive analytics modules configured to generate forecasts for financial costs, medication demand patterns, and adverse event probabilities using machine learning algorithms and statistical modeling techniques. The system features financial modeling modules that analyze cost patterns associated with medication procurement, administration infrastructure, and insurance reimbursements, while demand forecasting modules predict medication needs based on seasonal trends, patient population changes, and treatment protocol modifications. Adverse event prediction modules identify risk factors using patient risk profiles and clinical outcome histories. The platform incorporates machine learning capabilities that continuously improve prediction accuracy using patient outcome data and administration patterns. Comprehensive reporting modules generate customized predictive reports for healthcare administrators, pharmaceutical suppliers, and insurance providers, while optimization modules recommend actions for cost reduction and patient safety improvement based on predictive insights.

The drug injection device according to the present invention comprises: a drug storage unit the thickness of which varies according to the amount of drug to be injected; a pump assembly which is connected to the drug storage unit, and draws in and discharges the drug stored in the drug storage unit; and a drug injection detection unit which detects a change in the thickness of the drug storage unit and controls the operation of the drug injection device according to the change in the amount of the drug stored.

The present invention relates to an injection amount measurement and management system for mounting on a pen-type injection device (1) having an injection button that does not rotate during injection, in order to measure the injection amount of a drug, and relates to an injection amount measurement and management system (100) for mounting on the dose-setting knob of a pen-type injection device, the system comprising: a main body (110) in which a main body IMU sensor (112) is installed; an injection button interlocking part (120) which is mounted so as to be interlocked with the rotational operation of an injection button (11) of the pen-type injection device (1) and has an injection button IMU sensor (121) installed therein; a main control unit (130); and an input / output interface (140), wherein the main control unit (130) calculates a relative angle change value (RA) between a measurement value of the main body IMU sensor (112) and a measurement value of the injection button IMU sensor (121), acquires a drug dose calculation value using the relative angle change value (RA) until injection is completed when the relative angle change value (RA) occurs in a return rotation direction, and then manages and displays the drug dose calculation value as injection history information.

The invention discloses a medicine injection device capable of realizing automatic thrombolysis administration, which comprises a driving device, a mounting control valve, a thrombolysis medicine bag, a thrombolysis catheter and an injector, the driving device is provided with the mounting control valve, the mounting control valve is connected with the thrombolysis medicine bag, the mounting control valve is connected with the thrombolysis catheter, the mounting control valve is connected with the injector, and the injector is connected with the thrombolysis medicine bag. The driving device comprises a motor and a sensor, the motor is connected with the installation control valve, the sensor is connected with the injector, and the sensor is connected with the motor. By the adoption of the technical scheme, the medicine injection device which is convenient and rapid and capable of achieving automatic thrombolysis medicine administration is manufactured, automatic medicine taking or medicine injection can be achieved by automatically controlling steering of the installation control valve installed on the driving device, and meanwhile an interval medicine administration mode is designed according to the characteristics of thrombolysis medicine administration. And the interval administration time, the pulse amount and the pulse administration rate can be conveniently set clinically, so that personalized thrombolysis administration is realized, and more effective thrombolysis treatment is realized.

Stable, ready-to-use injectable pharmaceutical compositions are provided, comprising the combination of neostigmine, glycopyrrolate, and a pharmaceutically acceptable liquid vehicle, optionally with additional pharmaceutically acceptable excipients. Other aspects of the invention relate to methods for making such compositions and methods of using such compositions for reversing the effects of non-depolarizing neuromuscular blocking agents. Preferably, the composition comprises neostigmine methylsulfate, glycopyrronium bromide, and a pharmaceutically acceptable liquid vehicle, and is provided in a pre-filled, ready-to-use sealed container, such as a pre-filled syringe, suitable for intravenous administration.

The present disclosure provides a solid composition comprising a plurality of particles, where the particles can include a biopharmaceutical agent and a polyacrylamide-based copolymer, and optionally a stabilizing agent. Further provided are injectable pharmaceutical compositions including the particles suspended in a liquid carrier. The inventors have demonstrated that particular polyacrylamide-based copolymers can be used as stabilizing excipients in particle formulations of biopharmaceutical agents, without interacting directly with the biopharmaceutical agent, or altering its pharmacokinetic properties. The pharmaceutical composition can be formulated for injection to a patient. Also provided is a syringe loaded with the injectable pharmaceutical composition, methods of administering via injection a therapeutically effective dose of a biopharmaceutical to a subject in need thereof.

1. Name of the product in this design: Anti-slip grip syringe (nucleoside). 2. Purpose of this design: As a medical device, used for injecting drugs into patients. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: a 3D model.

The invention provides a multi-dimensional electronic regulation and control microneedle injection medicine introduction system, and belongs to the technical field of medical instruments. The system comprises a shell, a user interaction module, a control and drive module, a drive execution module and a microneedle module integrated with an adjustment protection device. The user interaction module is used for realizing multi-parameter collaborative setting and real-time display of injection pressure, dose and speed through a display screen and a control key; the control and driving module generates a regulation and control instruction according to the set parameters; the driving execution module accurately controls liquid medicine conveying according to the instruction; an adjusting protection device of the microneedle module can control the penetration depth of the microneedle and provide protection when the microneedle module is not used. By means of electronic integrated control, multi-dimensional, quantifiable and self-adaptive precise regulation and control of the drug introduction process are achieved, the safety, effectiveness and operation convenience of injection are effectively improved, and the system is suitable for various drug administration scenes such as clinic and families.

A method of providing a personal drug injection system is disclosed. The method comprises determining at least one anthropometric characteristic from a person, and providing a plurality of types of personal drug injection systems. Each personal drug injection system of a personal drug injection system type is configured so as to fit with a part of the person's body that is intended to receive an injectable drug, and includes a drug injection location set that includes at least one defined drug injection location corresponding to a location of a drug injection site on the part of the person's body when the personal drug injection system is disposed on the part of the person's body. Each personal drug injection system type is associated with a defined range of anthropometric characteristics that is different to the defined range of anthropometric characteristics associated with the other personal drug injection system types.

The present invention discloses an injectable pharmaceutical composition comprising flecainib or a pharmaceutically acceptable salt thereof. The present invention specifically discloses a dilution type injectable composition comprising flecainib or a pharmaceutically acceptable salt thereof and at least one osmotic pressure regulator.

This invention relates to the field of pharmaceutical technology, and particularly to the application of thiostrepton in the preparation of drugs for the prevention and treatment of scleroderma. The application of thiostrepton provides a new treatment approach for a wide range of scleroderma patients, offering clinicians and patients more options. For scleroderma patients intolerant to immunosuppressants, thiostrepton can provide topical, oral, or injectable treatments, avoiding the toxic side effects of immunosuppressants. Thiostrepton can be chemically synthesized, making it less expensive than biological agents. Furthermore, as a drug, it has been approved for use in animals, with fewer and milder side effects.

A method, computer program product, and computer system for a platform for managing injectable medication administration alerts. The platform may include: a server configured to receive administration data from an intelligent injection device, a database configured to store treatment schedules, an artificial intelligence module configured to categorize injection events based on compliance with treatment schedules, and an alerts module configured to: generate and send notifications based on injection event categorization, deliver alerts related to health, biometrics, medications and injections, provide visual and audible outputs regarding injection administration, and warn users about detected behaviors that may negatively impact treatment.

The invention discloses a multi-channel infusion suite and a using method thereof, and particularly relates to the technical field of medical instruments.The multi-channel infusion suite comprises a suite body, a groove is formed in the middle of the suite body, a liquid cavity is formed in the bottom of the suite body, an exhaust assembly is fixedly connected to the inner wall of the side of the groove, and the exhaust assembly is connected with the groove through a filtering film; the external member main body is fixedly connected with an output pipe connected with the inclined tee joint; at least two tube body connecting pieces are fixedly installed at one end of the kit body, one-way valves are fixedly installed in the tube body connecting pieces, and the tube body connecting pieces are fixedly connected with an infusion tube or a medicine infusion tube. One end of the inclined tee joint is used for injecting medicine. Medicine is directly injected into the inclined tee joint, an existing infusion channel does not need to be disconnected, and therefore the rescue efficiency is improved; gas in infusion liquid is automatically exhausted through the hydrophobic filter, and the liquid in the infusion liquid is prevented from flowing out of the sealing groove; the filter membrane is fixed by the fixing block, so that the liquid medicine is filtered by the filter membrane.

A method of providing a personal drug injection system is disclosed. The method comprises determining at least one anthropometric characteristic from a person, and providing a plurality of types of personal drug injection systems. Each personal drug injection system of a personal drug injection system type is configured so as to fit with a part of the person's body that is intended to receive an injectable drug, and includes a drug injection location set that includes at least one defined drug injection location corresponding to a location of a drug injection site on the part of the person's body when the personal drug injection system is disposed on the part of the person's body. Each personal drug injection system type is associated with a defined range of anthropometric characteristics that is different to the defined range of anthropometric characteristics associated with the other personal drug injection system types, and each personal drug injection system type has an associated drug injection location set that is different to the drug injection location set of the other personal drug injection system types. The method also involves using the determined anthropometric characteristic and the defined ranges of anthropometric characteristics to select one of the personal drug injection system types from the plurality of personal drug injection system types already manufactured, and providing the person with the selected personal drug injection system type.

The present application relates to a drive assembly for a drug delivery system, comprising a plunger member configured to engage and move a stopper within a container, a biasing member configured to move the plunger member, and an adjustable spacer assembly positioned between the plunger member and the stopper. The spacer assembly comprises a spacer element attached to the stopper and at least one compensator, or comprises a spacer element and a holder to which the spacer element is attached. The holder can be attached to the stopper and the spacer element can be attached to the holder by a threaded engagement. Further, the present application relates to a drug delivery system for injecting a drug, comprising a container configured to receive a drug, the container comprising a stopper configured to move within the container and a closure, a drive assembly as described above, and a needle actuator assembly.

1. Name of the product in this design: Torsion Spring Pen. 2. Purpose of this design: A reusable autoinjector for injecting drugs. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: a 3D model.

1. Name of the product in this design: Pen-type Injector (Type B). 2. Purpose of this design: For injecting drugs. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1. 5. Other situations requiring explanation: The top view enlarged view is an enlarged view of the top view; the bottom view enlarged view is an enlarged view of the bottom view.

An intelligent dosing platform incorporating comprehensive governance and regulatory compliance capabilities for injectable medication administration. The platform includes regulatory tracking modules configured to monitor compliance with Merit-based Incentive Payment System (MIPS) requirements, STAR quality metrics for Medicare and Medicaid programs, and federal fraud, waste, and abuse (FWA) program standards. The system features audit trail generation modules that create tamper-proof documentation with cryptographic signatures and immutable timestamping for regulatory reporting and compliance validation activities. Compliance assessment modules evaluate medication administration events against regulatory benchmarks and quality performance indicators, while automated reporting systems generate submissions for oversight bodies and fraud prevention agencies. The platform incorporates fraud detection capabilities, compliance dashboard visualization, risk assessment modules, and real-time alert systems to ensure comprehensive regulatory compliance and audit trail management across healthcare networks and injectable medication administration environments.

A device may include a barrel in fluid communication with a needle. A device may include a piston comprising a plunger. A device may include a microprocessor in electronic communication with a wireless module. A device may include sensors for detecting injection parameters. A device may include a supply chain tracking system configured to: monitor distribution of a plurality of intelligent injection devices containing an injectable medication, verify an inventory of the injectable medication, track inventory levels, record usage data of the plurality of intelligent injection devices, transmit an update to the inventory based on the recorded usage; and forecast a future inventory level for the injectable medication.

1. The name of the design product: stereotactic apparatus (JS302). 2. The use of the design product: using the three-dimensional coordinate system defined by the marks on the skull or other reference points to determine the location of certain subcortical neural structures in order to stimulate, destroy, inject drugs, guide potential, etc. under non-direct exposure. 3. The design points of the design product: in shape. 4. The picture or photo that best shows the design points: stereogram 1.

The present application relates to the field of syringes, in particular to a pen syringe, comprising a pen body, an injection mechanism, a locking mechanism and an identification member, the injection mechanism comprises an injection plunger, the injection plunger and a medicine cartridge are distributed along the axial direction of the pen body, the injection plunger can push out the medicine in the medicine container; the locking mechanism is configured to lock and unlock the injection plunger along the axial direction of the pen body; the identification member is connected to the pen body and is linked with the locking mechanism, when the pen syringe has not injected medicine, the identification member is in a to-be-injected state capable of moving along the axial direction of the pen body, and when the identification member moves a preset stroke, the identification member can drive the locking mechanism to unlock the injection plunger; after the pen syringe injects medicine, the identification member is in an injected state locked by the locking mechanism. The pen syringe of the present application can lock the injection plunger through the locking mechanism before injection to prevent accidental triggering, and after completing injection, the state of the identification member can be used to quickly identify whether the pen syringe has been used to prevent incorrect handling.

A drug delivery system for injecting a medicament, comprising: a container configured to receive a medicament; a drive assembly configured to expel the medicament from the container upon actuation; a needle for injecting the medicament into a patient; a needle actuator assembly comprising a movable portion biased by a biasing member and configured to move the needle between a pre-use position, a use position for delivering the medicament to the patient, and a post-use position after completion of delivery of the medicament; and a tube in fluid communication with the container and the needle, the tube comprising an expandable portion having an expanded state and a non-expanded state, wherein the expandable portion is configured to be in the expanded state upon actuation of the drive assembly and in the non-expanded state when the needle is in the post-use position.

A preparation of PEGylated solid lipid core nanocarriers (SLN) is loaded with at least one drug for delivery to a subject. SLNs having a small size, neutral charge, and high drug encapsulation efficiency are formed. PEGylation improves SLN permeability without hindering cellular uptake, particularly permeability of nasal mucous for intranasal delivery. PEGylated SLNs are suitable for intranasal, inhaled, oral or injected drug delivery. Exemplary formulations include a combined antiretroviral therapy (cART) designed to cross the blood-brain barrier and treat neuroAIDS.